Deck Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.6M

  • Investors
  • 3

Deck Bio General Information

Description

Developer of cell receptor therapeutics targeting highly expressed cancer specific peptide MHCs, intended to develop a single drug to increase response rates and reduce drug resistance for cancer patients. The company's platform is developing a proprietary technology to enable multi target recognition with a single drug, supporting higher response rates and reduced treatment resistance, enabling oncology researchers and biopharmaceutical companies seeking new immuno oncology approaches to advance targeted cancer therapies for a broader patient population.

Contact Information

Website
deck.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Cambridge, MA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Cambridge, MA
  • United States

Deck Bio Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deck Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 09-Apr-2026 $2.6M Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Mar-2026 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Sep-2024 $500K $500K Completed Pre-Clinical Trials
To view Deck Bio’s complete valuation and funding history, request access »

Deck Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deck Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Impact Ventures Venture Capital Minority
ACS BrightEdge Corporate Venture Capital Minority
Mission BioCapital Venture Capital Minority
To view Deck Bio’s complete investors history, request access »

Deck Bio FAQs

  • When was Deck Bio founded?

    Deck Bio was founded in 2023.

  • Where is Deck Bio headquartered?

    Deck Bio is headquartered in Cambridge, MA.

  • What is the size of Deck Bio?

    Deck Bio has 2 total employees.

  • What industry is Deck Bio in?

    Deck Bio’s primary industry is Drug Discovery.

  • Is Deck Bio a private or public company?

    Deck Bio is a Private company.

  • What is Deck Bio’s current revenue?

    The current revenue for Deck Bio is .

  • How much funding has Deck Bio raised over time?

    Deck Bio has raised $3.1M.

  • Who are Deck Bio’s investors?

    Impact Ventures, ACS BrightEdge, and Mission BioCapital have invested in Deck Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process